These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9211023)

  • 21. Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis.
    Packer M; Antonopoulos GV; Berlin JA; Chittams J; Konstam MA; Udelson JE
    Am Heart J; 2001 Jun; 141(6):899-907. PubMed ID: 11376302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy.
    Cinquegrana G; D'Aniello L; Landi M; Spinelli L; Grande G; De Prisco F; Petretta M
    J Card Fail; 2005 Apr; 11(3):213-9. PubMed ID: 15812750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction.
    Wei S; Chow LT; Sanderson JE
    J Am Coll Cardiol; 2000 Jul; 36(1):276-81. PubMed ID: 10898446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does beta-blocker treatment influence central sleep apnoea?
    Köhnlein T; Welte T
    Respir Med; 2007 Apr; 101(4):850-3. PubMed ID: 17223328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
    Lowes BD; Gilbert EM; Abraham WT; Minobe WA; Larrabee P; Ferguson D; Wolfel EE; Lindenfeld J; Tsvetkova T; Robertson AD; Quaife RA; Bristow MR
    N Engl J Med; 2002 May; 346(18):1357-65. PubMed ID: 11986409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol).
    Blanchet M; Ducharme A; Racine N; Rouleau JL; Tardif JC; Juneau M; Marquis J; Larivée L; Nigam A; Fortier A; White M
    Am J Cardiol; 2003 Sep; 92(5):548-53. PubMed ID: 12943875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic and energetic comparison of bucindolol and metoprolol for the treatment of congestive heart failure.
    Heesch CM; Marcoux L; Hatfield B; Eichhorn EJ
    Am J Cardiol; 1995 Feb; 75(5):360-4. PubMed ID: 7856528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E; Kurum T
    Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of effects of carvedilol versus metoprolol on cytokine levels in patients with idiopathic dilated cardiomyopathy.
    Ohtsuka T; Hamada M; Saeki H; Ogimoto A; Hiasa Go; Hara Y; Shigematsu Y; Hiwada K
    Am J Cardiol; 2002 Apr; 89(8):996-9. PubMed ID: 11950447
    [No Abstract]   [Full Text] [Related]  

  • 32. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy.
    Rahko PS
    Echocardiography; 2005 Aug; 22(7):547-54. PubMed ID: 16060890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
    J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carvedilol exerts more potent antiadrenergic effect than metoprolol in heart failure.
    Kohno T; Yoshikawa T; Yoshizawa A; Nakamura I; Anzai T; Satoh T; Ogawa S
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):347-55. PubMed ID: 16382297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative left ventricular functional and neurohumoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy.
    Hirooka K; Yasumura Y; Ishida Y; Hanatani A; Nakatani S; Komamura K; Hori M; Yamagishi M; Miyatake K
    Jpn Circ J; 2001 Nov; 65(11):931-6. PubMed ID: 11716241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carvedilol.
    Cohn LJ
    N Engl J Med; 1999 May; 340(18):1443-4. PubMed ID: 10328713
    [No Abstract]   [Full Text] [Related]  

  • 38. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.
    Metra M; Nodari S; Parrinello G; Giubbini R; Manca C; Dei Cas L
    Am Heart J; 2003 Feb; 145(2):292-9. PubMed ID: 12595847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
    Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
    Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
    Naya M; Tsukamoto T; Morita K; Katoh C; Nishijima K; Komatsu H; Yamada S; Kuge Y; Tamaki N; Tsutsui H
    J Nucl Med; 2009 Feb; 50(2):220-5. PubMed ID: 19164238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.